Q2 EPS Estimates for Legend Biotech Lifted by HC Wainwright
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Equities research analysts at HC Wainwright boosted their Q2 2025 earnings estimates for shares of Legend Biotech in a research note issued on Wednesday, May 14th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings per share of $0.36 for the quarter, up […]
